Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CPRT vs GSK✓SelectedUSD · GSKCPRT vs GSK performance historyLatest closeAs of+0.75%11/20
Stock and ETF performance explorer

CPRT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+342.2%
GSK return
+97.4%
Excess return
+244.8%
Maximum drawdown
-58.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-0.1%+0.9%+0.8%
7D-2.3%-5.3%+3.0%-0.6%
30D+12.7%-3.7%+16.3%+14.0%
3M-9.4%-7.3%-2.2%-7.3%
6M-5.9%-4.2%-1.7%-4.7%
YTD-20.6%+0.9%-21.5%-21.3%
1Y-24.2%+7.3%-31.5%-26.5%
3Y-38.9%+52.7%-91.6%-49.1%
5Y-18.4%+40.1%-58.5%-30.8%
All+342.2%+97.4%+244.8%+220.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling